CalciMedica (CALC) Stock Chart & Stock Price History $3.05 +0.19 (+6.64%) (As of 11:14 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CalciMedica Stock Price Performance 5 Day Performance+10.87%1 Month Performance-9.73%3 Month Performance-32.30%6 Month Performance-34.33%Year-To-Date Performance+6.99%1 Year Performance+2.00% Receive CALC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. Email Address Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. CALC Stock Chart for Thursday, December, 26, 2024 CALC Chart by TradingView CalciMedica Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/25/2024$2.86$2.86$2.86$2.776,638 shs$38.56 million12/24/2024$2.76$2.86+3.62%$2.86$2.776,638 shs$38.56 million12/23/2024$2.76$2.76$2.85$2.7118,995 shs$37.21 million12/20/2024$2.77$2.76-0.36%$2.89$2.7668,617 shs$37.21 million12/19/2024$2.74$2.77+1.09%$2.80$2.6721,156 shs$37.35 million12/18/2024$2.78$2.74-1.44%$2.90$2.7423,521 shs$36.94 million Get the Latest News and Ratings for CALC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024$2.81$2.78-1.07%$2.84$2.7114,884 shs$37.48 million12/16/2024$2.73$2.81+2.93%$2.83$2.7316,793 shs$37.88 million12/13/2024$2.79$2.73-2.15%$2.83$2.7037,537 shs$36.81 million12/12/2024$2.70$2.79+3.33%$2.84$2.6818,566 shs$37.62 million12/11/2024$2.75$2.70-1.82%$2.86$2.55167,613 shs$36.40 million12/10/2024$2.95$2.75-6.78%$2.96$2.7387,680 shs$37.08 million12/09/2024$2.86$2.95+3.15%$3.03$2.92106,398 shs$39.77 million12/06/2024$2.99$2.86-4.35%$3.05$2.05499,897 shs$38.55 million12/05/2024$3.05$2.99-1.97%$3.27$2.7879,221 shs$40.31 million12/04/2024$3.12$3.05-2.24%$3.20$3.0248,773 shs$41.11 million12/03/2024$3.43$3.12-9.04%$3.46$3.0491,053 shs$42.06 million12/02/2024$3.45$3.43-0.58%$3.50$3.4114,939 shs$46.24 million11/29/2024$3.44$3.45+0.29%$3.49$3.375,464 shs$46.51 million11/28/2024$3.44$3.44$3.49$3.3822,468 shs$46.38 million11/27/2024$3.39$3.44+1.47%$3.49$3.3822,468 shs$46.38 million11/26/2024$3.53$3.39-3.97%$3.53$3.3930,381 shs$45.70 million11/25/2024$3.45$3.53+2.32%$3.55$3.4049,972 shs$47.58 million Related Companies 2seventy bio Stock Price Chart Elutia Stock Price Chart Sagimet Biosciences Stock Price Chart Adaptimmune Therapeutics Stock Price Chart FitLife Brands Stock Price Chart Biomea Fusion Stock Price Chart InflaRx Stock Price Chart Nanobiotix Stock Price Chart Aligos Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Receive CALC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CALC) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredThe Key to Feeding 8.1 Billion PeopleImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
